Abstract
Introduction: The recent examples of newly emerged diseases that causes alarming situation globally include H1N1, Congo Hemorrhagic fever, Ebola virus diseases, Nipah Virus Infection, Lassa Fever and newly declared global emergency pandemic SARS nCOVID-19 infection. Since its emergence, it has spread around the globe. It tends to spread by the inhalation of the respiratory aerosols, direct human contact.
 Materials and Methods: This analytical study was carried out among the healthcare workers and people who received either of Covishield or Covaxin. The online survey questionnaire was prepared and data obtained through the responses to the survey proforma.
 Results: 86.17% respondents were above 40 years, 69.15% males and 30.85% were females. 89.36% were vaccinated with Covishield and 10.64% by Covaxin. 75.53% respondents experienced post vaccination symptoms; commonest were the local pain at injection site (28.72%), fever (12.76%), Myalgia (12.77%). The symptoms were found more in respondents with any of co-morbid condition.
 Discussion: Covishield was used more commonly than Covaxin in study samples. The symptoms following vaccination were more common in 40-60 age group and persons with co-morbid conditions.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
